Fda Oks All-embracing Abasement Biologic
The FDA has acclimatized a all-embracing adjustment of the antidepressant Lexapro (escitalopram oxalate).
The all-embracing tablets will be attainable in three doses: 5 milligrams, 10 milligrams, and 20 milligrams. The biologic is a accurate serotonin reuptake inhibitor (SSRI), a ancestors of drugs that aswell includes Prozac, Celexa, Zoloft, and Paxil.
Brand-name Lexapro -- bogus by Forest Laboratories, Inc. -- is the No. 2 antidepressant in abounding prescriptions and the No. 3 antidepressant for complete U.S. sales, as of February 2006, according to IMS Health Incorporated, a biologic exchange intelligence company.
The all-embracing adjustment of the biologic will be bogus by Ivax Corp., a Miami-based accent of Israel's Teva Biologic Industries.
A Teva annual absolution states that "Teva is currently in credible activity applicable this product" in a U.S. collective court.
The FDA has not arise abounding admonition on all-embracing escitalopram oxalate's approval history and labeling.
Similiars
- Fda Oks New Bacterial Vaginosis Biologic- Fda Oks New Top Claret Burden Biologic
- Fda Oks New Diabetes Biologic Admixture
- Fda Oks All-encompassing Antidepressant Effexor
- Fda Oks New Sunscreen
- Fda Oks New Implantable Contraceptive
- Fda Oks Macular Abatement Biologic
- Fda Oks Biologic For Parkinson's Dementia
- Fda Oks 1st All-embracing Adjustment Of Zocor
- Fda Oks The Adversity Biologic Opana